{"id":263,"date":"2023-02-21T21:22:33","date_gmt":"2023-02-21T21:22:33","guid":{"rendered":"https:\/\/new.vwdtest.com\/lt\/?page_id=263"},"modified":"2024-02-19T10:34:40","modified_gmt":"2024-02-19T10:34:40","slug":"legal-statement","status":"publish","type":"page","link":"https:\/\/vwdtest.com\/lt\/legal-statement\/","title":{"rendered":"Teisinis parei\u0161kimas"},"content":{"rendered":"<div class=\"default-block container\">\n<h2>Naudojimo s\u0105lygos<\/h2>\n<\/div>\n\n<div class=\"default-block container\">\n<p>\u0160i\u0105 svetain\u0119 finansuoja Octapharma AG, Seidenstrasse 2, 8853 Lachen SZ, \u0160veicarija ir sukurta bendradarbiaujant su medicinos ekspertais Dr. Fernando Corrales-Medina (Miamio universiteto-Millero medicinos mokyklos klinikin\u0117s pediatrijos docentas, JAV), profesorius Erikas. Berntorp (Lund universiteto, \u0160vedija, klinikini\u0173 koaguliacijos tyrim\u0173 profesorius) ir j\u0173 tarptautini\u0173 kraujavimo sutrikim\u0173 ekspert\u0173 komanda (toliau \u2013 Tarptautin\u0117 ekspert\u0173 grup\u0117).<\/p>\n<\/div>\n\n<div class=\"default-block container\">\n<p>Tai nereklamin\u0117 svetain\u0117, skirta paremti informavimo apie ligas kampanij\u0105, kuriai vadovauja Tarptautin\u0117 ekspert\u0173 grup\u0117, ir skirta tik bendriems informacijos tikslams. Nieko \u0161ioje svetain\u0117je netur\u0117tum\u0117te suprasti kaip bet kokio produkto ar bet kurio Octapharma \u012fmoni\u0173 grup\u0117s produkto naudojimo skatinimo ar reklamos.<\/p>\n<\/div>\n\n<div class=\"default-block container\">\n<p>Octapharma AG kartu su savo subrangovais palaiko interneto svetaini\u0173 prie\u017ei\u016br\u0105 ir valdym\u0105. Naudodamiesi \u0161ia svetaine sutinkate laikytis toliau nurodyt\u0173 s\u0105lyg\u0173 ir vis\u0173 taikom\u0173 \u012fstatym\u0173. Jei nesutinkate laikytis \u0161i\u0173 s\u0105lyg\u0173, nesinaudokite \u0161ia svetaine.<\/p>\n<\/div>\n\n<div class=\"default-block container\">\n<h2>Svetain\u0117s ir naudojimo s\u0105lyg\u0173 pakeitimai<\/h2>\n<\/div>\n\n<div class=\"default-block container\">\n<p>Octapharma AG pasilieka teis\u0119 bet kuriuo metu ir be \u012fsp\u0117jimo keisti, modifikuoti, papildyti, i\u0161trinti ir pataisyti \u0161i\u0105 svetain\u0119. Octapharma AG taip pat gali bet kuriuo metu be \u012fsp\u0117jimo at\u0161aukti prieig\u0105 prie \u0161ios svetain\u0117s.<\/p>\n<\/div>\n\n<div class=\"default-block container\">\n<p>Octapharma AG gali bet kuriuo metu retkar\u010diais per\u017ei\u016br\u0117ti \u0161ias naudojimo s\u0105lygas atnaujinama \u0161\u012f \u012fra\u0161\u0105. Jei \u0161ioje svetain\u0117je, esate saistomi bet koki\u0173 toki\u0173 patais\u0173, tod\u0117l ir toliau periodi\u0161kai lankot\u0117s \u0161iame puslapyje ir per\u017ei\u016br\u0117kite naudojimo s\u0105lygas, kad b\u016btum\u0117te tikri, jog suprantate tuo galiojan\u010dias s\u0105lygas.<\/p>\n<\/div>\n\n<div class=\"default-block container\">\n<h2>Apsauga nuo virus\u0173<\/h2>\n<\/div>\n\n<div class=\"default-block container\">\n<p>Octapharma AG negarantuoja ir negarantuoja, kad \u0161i svetain\u0117 arba el. lai\u0161kai, gauti i\u0161 Octapharma AG pagal adres\u0173 s\u0105ra\u0161o funkcij\u0105, bus nepertraukiami, be virus\u0173 ar be kit\u0173 kenksming\u0173 komponent\u0173. \u201eOctapharma AG\u201c (\u012fskaitant jos direktorius, filialus, pareig\u016bnus, darbuotojus, agentus, rangovus, \u012fp\u0117dinius ir \u012fgaliotinius) neprisiima jokios atsakomyb\u0117s u\u017e joki\u0105 \u017eal\u0105, padaryt\u0105 j\u016bs\u0173 \u012frangai d\u0117l prisijungimo prie \u0161ios svetain\u0117s, bet kokio turinio atsisiuntimo i\u0161 \u0161ios svetain\u0117s arba el. lai\u0161k\u0173 gavimas i\u0161 Octapharma AG pagal adres\u0173 s\u0105ra\u0161o funkcij\u0105.<\/p>\n<\/div>\n\n<div class=\"default-block container\">\n<h2>Medicinin\u0117 informacija<\/h2>\n<\/div>\n\n<div class=\"default-block container\">\n<p>Svetain\u0117s medicinin\u012f turin\u012f suk\u016br\u0117 ir patvirtino Tarptautin\u0117 ekspert\u0173 grup\u0117. Be to, \u0161i informacija n\u0117ra skirta pateikti i\u0161sami\u0105 medicinin\u0119 informacij\u0105. Visada tur\u0117tum\u0117te gauti i\u0161sami\u0105 medicinin\u0119 informacij\u0105 apie savo receptinius vaistus ar medicinos prietaisus (\u012fskaitant j\u0173 nauding\u0105 medicinin\u012f naudojim\u0105 ir galim\u0105 neigiam\u0105 poveik\u012f), aptardami tinkam\u0105 bet kurio vaisto \/ medicinos prietais\u0173 naudojim\u0105 tiesiogiai su recept\u0105 i\u0161ra\u0161iusiu gydytoju arba, jei reikia, su kitu medicinos patar\u0117ju. Pateikta medicinin\u0117 informacija n\u0117ra ir neskatina rekomenduoti, pirkti, i\u0161ra\u0161yti, parduoti ar administruoti konkret\u0173 Octapharma \u012fmoni\u0173 grup\u0117s produkt\u0105.<\/p>\n<\/div>\n\n<div class=\"default-block container\">\n<h2>Autori\u0173 teisi\u0173 apsauga<\/h2>\n<\/div>\n\n<div class=\"default-block container\">\n<p>Visos \u0161ioje svetain\u0117je esan\u010dios med\u017eiagos autori\u0173 teis\u0117s priklauso Octapharma AG, jei nenurodyta kitaip.<\/p>\n<\/div>\n\n<div class=\"default-block container\">\n<p>Octapharma AG pasilieka visas teises \u012f \u0161ios svetain\u0117s turin\u012f ir dizain\u0105. Nebent Octapharma AG ra\u0161ti\u0161kai leido, j\u016bs negalite atgaminti, naudoti ar kopijuoti jokio \u0161ioje svetain\u0117je esan\u010dio turinio, \u012fskaitant pavadinimus, logotipus, dizain\u0105, informacij\u0105 apie gaminius ir bet koki\u0105 kit\u0105 \u0161ioje svetain\u0117je naudojam\u0105 med\u017eiag\u0105 \/ informacij\u0105 (toliau kartu vadinama \u201eInformacija\u201c. ). Negalite komerciniais tikslais naudoti jokios informacijos ir negalite leisti jokios informacijos \u012fr\u0117minti ar \u012fterpti \u012f kit\u0105 svetain\u0119 be i\u0161ankstinio ra\u0161ti\u0161ko Octapharma AG leidimo.<\/p>\n<\/div>\n\n<div class=\"default-block container\">\n<p>Visa informacija, nurodyta \u0161ioje svetain\u0117je, yra jos atitinkamo savininko nuosavyb\u0117 ir netur\u0117t\u0173 b\u016bti visi\u0161kai ar i\u0161 dalies naudojama jokioje jurisdikcijoje be i\u0161ankstinio ra\u0161ytinio jos savininko sutikimo. Taip pat netur\u0117t\u0173 b\u016bti naudojama jokia grafika, i\u0161 esm\u0117s pana\u0161i \u012f bet kur\u012f \u0161ioje svetain\u0117je nurodyt\u0105 prek\u0117s \u017eenkl\u0105, logotip\u0105 ar pavadinim\u0105.<\/p>\n<\/div>\n\n<div class=\"default-block container\">\n<h2>Joki\u0173 garantij\u0173 ar atstovavimo<\/h2>\n<\/div>\n\n<div class=\"default-block container\">\n<p>Informacija pateikiama tokia, kokia yra, ir be joki\u0173 tiesiogini\u0173 ar numanom\u0173 garantij\u0173.<\/p>\n<\/div>\n\n<div class=\"default-block container\">\n<p>Tiek, kiek leid\u017eia \u012fstatymai, Octapharma AG ai\u0161kiai atsisako bet koki\u0173 parei\u0161kim\u0173 ir garantij\u0173, tiesiogini\u0173 ar numanom\u0173, susijusi\u0173 su \u0161ia svetaine arba jos at\u017evilgiu, \u012fskaitant, be apribojim\u0173, bet kokius parei\u0161kimus ar garantijas, susijusias su:<\/p>\n<\/div>\n\n<div class=\"default-block container\">\n<ul><div class=\"default-block container\">\n<li>bet kokios informacijos, esan\u010dios \u0161ioje svetain\u0117je, tikslum\u0105 ar i\u0161samum\u0105;<\/li>\n<\/div>\n\n<div class=\"default-block container\">\n<li>Bet kokios informacijos, esan\u010dios bet kurioje svetain\u0117je, susietoje su \u0161ia svetaine, tikslumas ar i\u0161samumas.<\/li>\n<\/div>\n\n<div class=\"default-block container\">\n<li>Informacija teikiama remiantis tuo, kad visi asmenys, besikreipiantys \u012f svetain\u0119, prisiima atsakomyb\u0119 u\u017e jos turinio tikslumo \u012fvertinim\u0105 ir visi\u0161kai ja pasitiki savo rizika. \u201eOctapharma AG\u201c (\u012fskaitant jos direktorius, filialus, pareig\u016bnus, darbuotojus, agentus, rangovus, \u012fp\u0117dinius ir \u012fgaliotinius) neprisiima jokios atsakomyb\u0117s u\u017e nuostolius ar \u017eal\u0105, kuri\u0105 bet kuris asmuo patyr\u0117 d\u0117l pasitik\u0117jimo informacija ar bet kokia kita informacija, \u012ftraukta \u012f nuorod\u0105. .<\/li>\n<\/div><\/ul>\n<\/div>\n\n<div class=\"default-block container\">\n<h2>Taikomas elgesio kodeksas<\/h2>\n<\/div>\n\n<div class=\"default-block container\">\n<p>Octapharma AG stengiasi laikytis IFPMA praktikos kodekso nuostat\u0173. Naujausi\u0105 min\u0117to kodo versij\u0105 rasite paspaud\u0119 \u0161i\u0105 nuorod\u0105:&nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.ifpma.org\/resource-centre\/ifpma-code-of-practice\/\" target=\"_blank\">https:\/\/www.ifpma.org\/resource-centre\/ifpma-code-of-practice\/<\/a><\/p>\n<\/div>\n\n<div class=\"default-block container\">\n<h2>\u012esipareigojim\u0173 ribojimas<\/h2>\n<\/div>\n\n<div class=\"default-block container\">\n<p>Jokiu atveju \u201eOctapharma AG\u201c (\u012fskaitant jos direktorius, filialus, pareig\u016bnus, darbuotojus, agentus, rangovus, teisi\u0173 per\u0117m\u0117jus ir \u012fgaliotinius) n\u0117ra atsakinga u\u017e joki\u0105 tiesiogin\u0119, netiesiogin\u0119, baud\u017eiam\u0105j\u0105, atsitiktin\u0119, speciali\u0105, pasekmin\u0119 \u017eal\u0105 ar bet koki\u0105 \u017eal\u0105, \u012fskaitant: be apribojim\u0173, nuostoli\u0173 d\u0117l naudojimo, duomen\u0173, pelno ar prarast\u0173 galimybi\u0173 praradimo, atsiradusio d\u0117l \u0161ios svetain\u0117s naudojimo ar veikimo ar bet kokiu b\u016bdu su juo susijusio.<\/p>\n<\/div>\n\n<div class=\"default-block container\">\n<h2>Tre\u010di\u0173j\u0173 \u0161ali\u0173 svetain\u0117<\/h2>\n<\/div>\n\n<div class=\"default-block container\">\n<p>Kad jums b\u016bt\u0173 patogiau, \u201eOctapharma AG\u201c \u0161ioje svetain\u0117je gali pateikti nuorodas \u012f kit\u0173 subjekt\u0173 valdomas svetaines. Jei naudosit\u0117s \u0161iomis svetain\u0117mis, i\u0161eisite i\u0161 \u0161ios svetain\u0117s. Jei nuspr\u0119site apsilankyti bet kurioje susietoje svetain\u0117je, tai darote prisiimdami rizik\u0105 ir esate atsakingi u\u017e vis\u0173 apsaugos priemoni\u0173, kad apsisaugotum\u0117te nuo virus\u0173 ar kit\u0173 \u017ealing\u0173 element\u0173.<\/p>\n<\/div>\n\n<div class=\"default-block container\">\n<p>\u201eOctapharma AG\u201c (\u012fskaitant jos direktorius, filialus, pareig\u016bnus, darbuotojus, agentus, rangovus, \u012fp\u0117dinius ir \u012fgaliotinius) neteikia joki\u0173 garantij\u0173 ar parei\u0161kim\u0173, susijusi\u0173 su jokiomis susietomis svetain\u0117mis ar jose rodoma informacija arba bet kokiu produktu arba jame apra\u0161ytas paslaugas.<\/p>\n<\/div>\n\n<div class=\"default-block container\">\n<p>Nuorodos nerei\u0161kia, kad \u201eOctapharma AG\u201c yra susijusi ar susijusi su arba yra teisi\u0161kai \u012fgaliota naudoti bet kok\u012f prek\u0117s \u017eenkl\u0105, prek\u0117s pavadinim\u0105, logotip\u0105 ar autori\u0173 teisi\u0173 simbol\u012f, rodom\u0105 arba pasiekiam\u0105 per nuorodas, arba kad bet kuri susieta svetain\u0117 yra \u012fgaliota naudoti bet koks Octapharma AG prek\u0117s \u017eenklas, prek\u0117s pavadinimas, logotipas ar autori\u0173 teisi\u0173 simbolis.<\/p>\n<\/div>\n\n<div class=\"default-block container\">\n<p>Visas nuorodas \u012f \u0161i\u0105 svetain\u0119 turi patvirtinti \u201eOctapharma AG\u201c. \u201eOctapharma AG\u201c pasilieka teis\u0119 bet kuriuo metu savo nuo\u017ei\u016bra at\u0161aukti \u0161\u012f sutikim\u0105 susieti.<\/p>\n<\/div>\n\n<div class=\"default-block container\">\n<h2>Taikytina teis\u0117<\/h2>\n<\/div>\n\n<div class=\"default-block container\">\n<p>\u0160ios naudojimo s\u0105lygos, taip pat parei\u0161kimas apie privatum\u0105 ir bet koki\u0173 gin\u010d\u0173, susijusi\u0173 su \u0161iomis naudojimo s\u0105lygomis ir (arba) privatumo parei\u0161kimu, sprendimas turi b\u016bti ai\u0161kinamas pagal \u0160veicarijos \u012fstatymus. I\u0161skirtin\u0117 jurisdikcijos vieta yra Lachenas, SZ, \u0160veicarija.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Naudojimo s\u0105lygos \u0160i\u0105 svetain\u0119 finansuoja Octapharma AG, Seidenstrasse 2, 8853 Lachen SZ, \u0160veicarija ir sukurta bendradarbiaujant su medicinos ekspertais Dr. Fernando Corrales-Medina (Miamio universiteto-Millero medicinos mokyklos klinikin\u0117s pediatrijos docentas, JAV), profesorius Erikas. Berntorp (Lund universiteto, \u0160vedija, klinikini\u0173 koaguliacijos tyrim\u0173 profesorius) ir j\u0173 tarptautini\u0173 kraujavimo sutrikim\u0173 ekspert\u0173 komanda (toliau \u2013 Tarptautin\u0117 ekspert\u0173 grup\u0117). Tai nereklamin\u0117 svetain\u0117, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"front-page.php","meta":{"inline_featured_image":false},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Teisinis parei\u0161kimas - Lithuania<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vwdtest.com\/lt\/legal-statement\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Teisinis parei\u0161kimas - Lithuania\" \/>\n<meta property=\"og:description\" content=\"Naudojimo s\u0105lygos \u0160i\u0105 svetain\u0119 finansuoja Octapharma AG, Seidenstrasse 2, 8853 Lachen SZ, \u0160veicarija ir sukurta bendradarbiaujant su medicinos ekspertais Dr. Fernando Corrales-Medina (Miamio universiteto-Millero medicinos mokyklos klinikin\u0117s pediatrijos docentas, JAV), profesorius Erikas. Berntorp (Lund universiteto, \u0160vedija, klinikini\u0173 koaguliacijos tyrim\u0173 profesorius) ir j\u0173 tarptautini\u0173 kraujavimo sutrikim\u0173 ekspert\u0173 komanda (toliau \u2013 Tarptautin\u0117 ekspert\u0173 grup\u0117). Tai nereklamin\u0117 svetain\u0117, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vwdtest.com\/lt\/legal-statement\/\" \/>\n<meta property=\"og:site_name\" content=\"Lithuania\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-19T10:34:40+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/vwdtest.com\/lt\/legal-statement\/\",\"url\":\"https:\/\/vwdtest.com\/lt\/legal-statement\/\",\"name\":\"Teisinis parei\u0161kimas - Lithuania\",\"isPartOf\":{\"@id\":\"https:\/\/vwdtest.com\/lt\/#website\"},\"datePublished\":\"2023-02-21T21:22:33+00:00\",\"dateModified\":\"2024-02-19T10:34:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/vwdtest.com\/lt\/legal-statement\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/vwdtest.com\/lt\/legal-statement\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/vwdtest.com\/lt\/legal-statement\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/vwdtest.com\/lt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Teisinis parei\u0161kimas\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/vwdtest.com\/lt\/#website\",\"url\":\"https:\/\/vwdtest.com\/lt\/\",\"name\":\"Lithuania\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/vwdtest.com\/lt\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Teisinis parei\u0161kimas - Lithuania","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vwdtest.com\/lt\/legal-statement\/","og_locale":"en_US","og_type":"article","og_title":"Teisinis parei\u0161kimas - Lithuania","og_description":"Naudojimo s\u0105lygos \u0160i\u0105 svetain\u0119 finansuoja Octapharma AG, Seidenstrasse 2, 8853 Lachen SZ, \u0160veicarija ir sukurta bendradarbiaujant su medicinos ekspertais Dr. Fernando Corrales-Medina (Miamio universiteto-Millero medicinos mokyklos klinikin\u0117s pediatrijos docentas, JAV), profesorius Erikas. Berntorp (Lund universiteto, \u0160vedija, klinikini\u0173 koaguliacijos tyrim\u0173 profesorius) ir j\u0173 tarptautini\u0173 kraujavimo sutrikim\u0173 ekspert\u0173 komanda (toliau \u2013 Tarptautin\u0117 ekspert\u0173 grup\u0117). Tai nereklamin\u0117 svetain\u0117, [&hellip;]","og_url":"https:\/\/vwdtest.com\/lt\/legal-statement\/","og_site_name":"Lithuania","article_modified_time":"2024-02-19T10:34:40+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/vwdtest.com\/lt\/legal-statement\/","url":"https:\/\/vwdtest.com\/lt\/legal-statement\/","name":"Teisinis parei\u0161kimas - Lithuania","isPartOf":{"@id":"https:\/\/vwdtest.com\/lt\/#website"},"datePublished":"2023-02-21T21:22:33+00:00","dateModified":"2024-02-19T10:34:40+00:00","breadcrumb":{"@id":"https:\/\/vwdtest.com\/lt\/legal-statement\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vwdtest.com\/lt\/legal-statement\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/vwdtest.com\/lt\/legal-statement\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/vwdtest.com\/lt\/"},{"@type":"ListItem","position":2,"name":"Teisinis parei\u0161kimas"}]},{"@type":"WebSite","@id":"https:\/\/vwdtest.com\/lt\/#website","url":"https:\/\/vwdtest.com\/lt\/","name":"Lithuania","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vwdtest.com\/lt\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/vwdtest.com\/lt\/wp-json\/wp\/v2\/pages\/263"}],"collection":[{"href":"https:\/\/vwdtest.com\/lt\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/vwdtest.com\/lt\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/vwdtest.com\/lt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/vwdtest.com\/lt\/wp-json\/wp\/v2\/comments?post=263"}],"version-history":[{"count":13,"href":"https:\/\/vwdtest.com\/lt\/wp-json\/wp\/v2\/pages\/263\/revisions"}],"predecessor-version":[{"id":2165,"href":"https:\/\/vwdtest.com\/lt\/wp-json\/wp\/v2\/pages\/263\/revisions\/2165"}],"wp:attachment":[{"href":"https:\/\/vwdtest.com\/lt\/wp-json\/wp\/v2\/media?parent=263"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}